ConductScience.org, home

Paper41540504

miR-22-Galectin-1 as an integral signaling axis in regulating metabolism and immunity in HCC.

Hu Y and 10 others. Biomark Res, 2026. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. miR-22-Galectin-1 as an integral signaling axis in regulating metabolism and immunity in HCC. Papers, record 41540504. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41540504

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
miR-22-Galectin-1 as an integral signaling axis in regulating metabolism and immunity in HCC.
PubMed
Journal
Biomark Res
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2026-05-09
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hu YYing
2Setayesh TTahereh
3Jena PKPrasant Kumar
4Ji YYutong
5Testerman TTrenton
6Liu RRuiwu
7Shih TCTsung-Chieh
8Wang XJXiao-Jing
9Liu FTFu-Tong
10Lam KSKit S
11Wan YYYu-Jui Yvonne

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P30 CA093373NCI NIH HHSUnited StatesP30CA093373PubMedNIH RePORTER
R01 CA222490NCI NIH HHSUnited StatesR01CA222490PubMedNIH RePORTER
R01CA222490NIH HHSUnited StatesR01CA222490PubMedNIH RePORTER

Download CSV of grants

References86

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127922690MicroRNA-152 inhibits tumor cell growth by directly targeting RTKN in hepatocellular carcinoma.Oncol Rep2017https://conductscience.org/library/papers/27922690PubMed
237254440Liver directed adeno-associated viral vectors to treat metabolic disease.J Inherit Metab Dis2024https://conductscience.org/library/papers/37254440PubMed
336703969Inhibition of galectins in cancer: Biological challenges for their clinical application.Front Immunol2022https://conductscience.org/library/papers/36703969PubMed
425175738All-trans retinoic acid regulates hepatic bile acid homeostasis.Biochem Pharmacol2014https://conductscience.org/library/papers/25175738PubMed
528055292Molecular control of Rab activity by GEFs, GAPs and GDI.Small GTPases2018https://conductscience.org/library/papers/28055292PubMed
638261802Targeting stroma and tumor, silencing galectin 1 treats orthotopic mouse hepatocellular carcinoma.Acta Pharm Sin B2024https://conductscience.org/library/papers/38261802PubMed
720943850Expression profile of microRNAs in serum: a fingerprint for esophageal squamous cell carcinoma.Clin Chem2010https://conductscience.org/library/papers/20943850PubMed
825042151OTX008, a selective small-molecule inhibitor of galectin-1, downregulates cancer cell proliferation, invasion and tumour angiogenesis.Eur J Cancer2014https://conductscience.org/library/papers/25042151PubMed
937835594Mannose-Binding Lectin 2 as a Potential Therapeutic Target for Hepatocellular Carcinoma: Multi-Omics Analysis and Experimental Validation.Cancers (Basel)2023https://conductscience.org/library/papers/37835594PubMed
1035325185DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update).Nucleic Acids Res2022https://conductscience.org/library/papers/35325185PubMed
1124496460Galectin-1 has potential prognostic significance and is implicated in clear cell renal cell carcinoma progression through the HIF/mTOR signaling axis.Br J Cancer2014https://conductscience.org/library/papers/24496460PubMed
1221880716Synergistic induction of galectin-1 by CCAAT/enhancer binding protein alpha and hypoxia-inducible factor 1alpha and its role in differentiation of acute myeloid leukemic cells.J Biol Chem2011https://conductscience.org/library/papers/21880716PubMed
1333005474MiR-22 as a metabolic silencer and liver tumor suppressor.Liver Res2020https://conductscience.org/library/papers/33005474PubMed
1429440144SPON2 Promotes M1-like Macrophage Recruitment and Inhibits Hepatocellular Carcinoma Metastasis by Distinct Integrin-Rho GTPase-Hippo Pathways.Cancer Res2018https://conductscience.org/library/papers/29440144PubMed
1537609633DoSurvive: A webtool for investigating the prognostic power of a single or combined cancer biomarker.iScience2023https://conductscience.org/library/papers/37609633PubMed
1630252536RARβ acts as both an upstream regulator and downstream effector of miR-22, which epigenetically regulates NUR77 to induce apoptosis of colon cancer cells.FASEB J2019https://conductscience.org/library/papers/30252536PubMed
177890630Galectin-1, a beta-galactoside-binding lectin in Chinese hamster ovary cells. I. Physical and chemical characterization.J Biol Chem1995https://conductscience.org/library/papers/7890630PubMed
1828892150Hepatic inflammation caused by dysregulated bile acid synthesis is reversible by butyrate supplementation.J Pathol2017https://conductscience.org/library/papers/28892150PubMed
1917043243Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy.Proc Natl Acad Sci U S A2006https://conductscience.org/library/papers/17043243PubMed
2031160556Pseudogene RACGAP1P activates RACGAP1/Rho/ERK signalling axis as a competing endogenous RNA to promote hepatocellular carcinoma early recurrence.Cell Death Dis2019https://conductscience.org/library/papers/31160556PubMed

See all 86 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
42529129Galectins at the crossroads of tumor immunity, metabolism, and metastasis: mechanisms, therapeutic resistance, and translational opportunities.Front Immunol2026https://conductscience.org/library/papers/42529129

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41540504

GET https://conductscience.org/api/papers/v1/41540504/references?page=2